12:00 AM
 | 
Mar 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Activated cellular therapy (ACT): Completed Phase I testing enrollment

Neoprobe Corp. (NEOP), Dublin, Ohio
Product: Activated cellular therapy (ACT), derived from RIGS technology
Indication: AIDS
Status: NEOP...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >